| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Otolaryngology | 14 | 2025 | 112 | 3.190 |
Why?
|
| Tonsillectomy | 11 | 2025 | 110 | 2.140 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 5 | 2025 | 32 | 1.930 |
Why?
|
| Pain, Postoperative | 7 | 2025 | 278 | 1.450 |
Why?
|
| Adenoidectomy | 9 | 2025 | 84 | 1.450 |
Why?
|
| Ankyloglossia | 2 | 2020 | 8 | 1.350 |
Why?
|
| Analgesics, Opioid | 6 | 2025 | 465 | 1.340 |
Why?
|
| Lingual Frenum | 7 | 2020 | 12 | 1.290 |
Why?
|
| Analgesics, Non-Narcotic | 3 | 2025 | 81 | 1.200 |
Why?
|
| Pharyngeal Muscles | 3 | 2013 | 11 | 1.160 |
Why?
|
| Acetaminophen | 3 | 2025 | 101 | 1.080 |
Why?
|
| Physician Assistants | 2 | 2025 | 74 | 1.030 |
Why?
|
| Hydrocodone | 2 | 2025 | 36 | 0.990 |
Why?
|
| Efficiency | 1 | 2025 | 67 | 0.930 |
Why?
|
| Preoperative Care | 3 | 2025 | 376 | 0.920 |
Why?
|
| School Admission Criteria | 2 | 2013 | 24 | 0.710 |
Why?
|
| Anti-Dyskinesia Agents | 2 | 2011 | 39 | 0.710 |
Why?
|
| Pediatrics | 5 | 2025 | 1215 | 0.690 |
Why?
|
| Laryngeal Neoplasms | 4 | 2010 | 104 | 0.690 |
Why?
|
| Certification | 1 | 2021 | 73 | 0.680 |
Why?
|
| Hemangioma | 4 | 2010 | 97 | 0.680 |
Why?
|
| Botulinum Toxins | 2 | 2011 | 122 | 0.640 |
Why?
|
| Tongue Diseases | 4 | 2003 | 10 | 0.610 |
Why?
|
| Mucormycosis | 1 | 2019 | 32 | 0.610 |
Why?
|
| Induction Chemotherapy | 1 | 2019 | 57 | 0.610 |
Why?
|
| Child | 37 | 2025 | 25870 | 0.570 |
Why?
|
| Internship and Residency | 4 | 2024 | 1250 | 0.540 |
Why?
|
| Education, Medical, Graduate | 2 | 2024 | 560 | 0.540 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2016 | 12 | 0.530 |
Why?
|
| Child, Preschool | 25 | 2025 | 14867 | 0.490 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2025 | 232 | 0.470 |
Why?
|
| Developing Countries | 1 | 2016 | 289 | 0.450 |
Why?
|
| Hearing Loss, Sensorineural | 4 | 2008 | 159 | 0.450 |
Why?
|
| Cricoid Cartilage | 2 | 2011 | 16 | 0.440 |
Why?
|
| Humans | 75 | 2025 | 134083 | 0.430 |
Why?
|
| Pharyngeal Diseases | 1 | 2013 | 20 | 0.430 |
Why?
|
| Infant | 24 | 2022 | 13230 | 0.420 |
Why?
|
| Job Application | 1 | 2013 | 21 | 0.420 |
Why?
|
| Personnel Selection | 1 | 2013 | 67 | 0.400 |
Why?
|
| Airway Obstruction | 3 | 2010 | 168 | 0.380 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 820 | 0.370 |
Why?
|
| Deglutition Disorders | 1 | 2013 | 147 | 0.370 |
Why?
|
| Pharynx | 1 | 2011 | 69 | 0.360 |
Why?
|
| Esophageal Achalasia | 1 | 2011 | 44 | 0.340 |
Why?
|
| Male | 48 | 2025 | 66092 | 0.340 |
Why?
|
| Neonatal Screening | 4 | 2008 | 193 | 0.320 |
Why?
|
| Retrospective Studies | 12 | 2025 | 17538 | 0.320 |
Why?
|
| Female | 46 | 2025 | 71892 | 0.320 |
Why?
|
| Drug Prescriptions | 2 | 2021 | 240 | 0.310 |
Why?
|
| Correspondence as Topic | 1 | 2008 | 12 | 0.300 |
Why?
|
| Clinical Competence | 4 | 2024 | 1062 | 0.290 |
Why?
|
| Tympanoplasty | 1 | 2008 | 11 | 0.290 |
Why?
|
| Dissection | 2 | 2007 | 58 | 0.290 |
Why?
|
| Breast Feeding | 2 | 2020 | 245 | 0.290 |
Why?
|
| Writing | 1 | 2008 | 65 | 0.280 |
Why?
|
| Anesthesia, General | 3 | 2025 | 125 | 0.270 |
Why?
|
| Speech Disorders | 3 | 2003 | 49 | 0.270 |
Why?
|
| Drug Combinations | 2 | 2025 | 285 | 0.260 |
Why?
|
| Endoscopy | 3 | 2019 | 287 | 0.250 |
Why?
|
| Mandibular Neoplasms | 2 | 2017 | 8 | 0.240 |
Why?
|
| Williams Syndrome | 1 | 2006 | 42 | 0.240 |
Why?
|
| Glucocorticoids | 4 | 2017 | 403 | 0.240 |
Why?
|
| Hospitals, Pediatric | 4 | 2025 | 791 | 0.240 |
Why?
|
| Fentanyl | 1 | 2025 | 54 | 0.230 |
Why?
|
| Premedication | 1 | 2004 | 42 | 0.230 |
Why?
|
| Otitis Media | 2 | 2002 | 86 | 0.220 |
Why?
|
| Electrocoagulation | 1 | 2004 | 33 | 0.220 |
Why?
|
| Cold Temperature | 1 | 2004 | 86 | 0.220 |
Why?
|
| Infant, Newborn | 11 | 2020 | 8617 | 0.220 |
Why?
|
| Hypoxia | 1 | 2025 | 268 | 0.210 |
Why?
|
| Hearing Tests | 1 | 2003 | 16 | 0.210 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2006 | 266 | 0.210 |
Why?
|
| United States | 8 | 2023 | 11762 | 0.200 |
Why?
|
| Steroids | 1 | 2004 | 213 | 0.200 |
Why?
|
| Palatine Tonsil | 3 | 2014 | 37 | 0.200 |
Why?
|
| Tongue | 1 | 2003 | 34 | 0.200 |
Why?
|
| Articulation Disorders | 1 | 2002 | 5 | 0.200 |
Why?
|
| Surgery, Oral | 1 | 2002 | 7 | 0.200 |
Why?
|
| Lymphadenitis | 1 | 2023 | 26 | 0.200 |
Why?
|
| Radiology | 1 | 2024 | 127 | 0.200 |
Why?
|
| Prospective Studies | 13 | 2019 | 6601 | 0.200 |
Why?
|
| Neck | 2 | 2020 | 143 | 0.200 |
Why?
|
| Tracheostomy | 2 | 2020 | 202 | 0.200 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2023 | 44 | 0.200 |
Why?
|
| Maxillary Sinus | 3 | 2016 | 12 | 0.190 |
Why?
|
| Pain Management | 2 | 2021 | 200 | 0.190 |
Why?
|
| Delphi Technique | 2 | 2021 | 240 | 0.190 |
Why?
|
| Treatment Outcome | 11 | 2022 | 13073 | 0.180 |
Why?
|
| Feasibility Studies | 1 | 2024 | 827 | 0.180 |
Why?
|
| Hearing Disorders | 1 | 2001 | 29 | 0.180 |
Why?
|
| Mycetoma | 1 | 2001 | 3 | 0.180 |
Why?
|
| Specialty Boards | 1 | 2021 | 21 | 0.180 |
Why?
|
| Otitis Externa | 1 | 2001 | 5 | 0.180 |
Why?
|
| Lymphatic System | 1 | 2001 | 21 | 0.180 |
Why?
|
| Middle Ear Ventilation | 3 | 2009 | 32 | 0.180 |
Why?
|
| Polysomnography | 2 | 2000 | 153 | 0.180 |
Why?
|
| Scedosporium | 1 | 2001 | 7 | 0.180 |
Why?
|
| Jugular Veins | 1 | 2001 | 78 | 0.180 |
Why?
|
| Length of Stay | 4 | 2020 | 1391 | 0.180 |
Why?
|
| Codeine | 1 | 2000 | 23 | 0.170 |
Why?
|
| Follow-Up Studies | 9 | 2015 | 5477 | 0.170 |
Why?
|
| Aneurysm | 1 | 2001 | 91 | 0.170 |
Why?
|
| Bevacizumab | 1 | 2021 | 79 | 0.170 |
Why?
|
| Vestibular Aqueduct | 1 | 2000 | 3 | 0.170 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2003 | 330 | 0.160 |
Why?
|
| Physicians, Women | 1 | 2020 | 52 | 0.160 |
Why?
|
| Adolescent | 13 | 2020 | 20609 | 0.160 |
Why?
|
| Head | 1 | 2020 | 113 | 0.160 |
Why?
|
| Retropharyngeal Abscess | 1 | 1999 | 8 | 0.160 |
Why?
|
| Cohort Studies | 3 | 2025 | 5217 | 0.160 |
Why?
|
| Fatal Outcome | 3 | 2007 | 377 | 0.160 |
Why?
|
| Awards and Prizes | 1 | 2020 | 72 | 0.160 |
Why?
|
| Drug Administration Schedule | 2 | 2011 | 756 | 0.160 |
Why?
|
| Sinusitis | 2 | 2017 | 114 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2024 | 3855 | 0.160 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2020 | 772 | 0.160 |
Why?
|
| Professional Role | 1 | 2019 | 72 | 0.150 |
Why?
|
| Injections, Intralesional | 3 | 2017 | 49 | 0.150 |
Why?
|
| Video Recording | 2 | 2019 | 202 | 0.150 |
Why?
|
| Lung | 1 | 2007 | 1576 | 0.150 |
Why?
|
| Tonsillitis | 2 | 2014 | 13 | 0.150 |
Why?
|
| Patient Satisfaction | 2 | 2020 | 490 | 0.150 |
Why?
|
| Nurse Practitioners | 1 | 2019 | 50 | 0.150 |
Why?
|
| Audiovisual Aids | 1 | 2019 | 24 | 0.150 |
Why?
|
| Velopharyngeal Insufficiency | 1 | 2019 | 19 | 0.150 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 1999 | 61 | 0.150 |
Why?
|
| Vestibular Diseases | 1 | 2000 | 68 | 0.150 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2021 | 220 | 0.150 |
Why?
|
| Epiglottis | 1 | 1998 | 9 | 0.150 |
Why?
|
| Larynx | 3 | 2009 | 78 | 0.150 |
Why?
|
| Hearing Loss | 2 | 2011 | 214 | 0.150 |
Why?
|
| Educational Measurement | 1 | 2021 | 332 | 0.150 |
Why?
|
| Digestive System | 1 | 1998 | 65 | 0.140 |
Why?
|
| Laryngoscopy | 3 | 2010 | 157 | 0.140 |
Why?
|
| Sleep Apnea Syndromes | 1 | 1999 | 81 | 0.140 |
Why?
|
| Esophagus | 2 | 1998 | 234 | 0.140 |
Why?
|
| Respiratory Tract Infections | 1 | 2021 | 294 | 0.140 |
Why?
|
| Respiratory System | 1 | 1998 | 98 | 0.140 |
Why?
|
| Otolaryngologists | 1 | 2017 | 9 | 0.140 |
Why?
|
| Prenatal Diagnosis | 2 | 2016 | 632 | 0.140 |
Why?
|
| Opioid-Related Disorders | 1 | 2021 | 285 | 0.140 |
Why?
|
| Histamine Antagonists | 1 | 2017 | 19 | 0.140 |
Why?
|
| California | 3 | 2004 | 144 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2011 | 1740 | 0.140 |
Why?
|
| Drinking Behavior | 1 | 1997 | 9 | 0.140 |
Why?
|
| Osteomalacia | 1 | 2017 | 7 | 0.130 |
Why?
|
| Haiti | 1 | 2016 | 10 | 0.130 |
Why?
|
| Giant Cell Tumors | 1 | 2017 | 5 | 0.130 |
Why?
|
| Maxillary Neoplasms | 1 | 2017 | 4 | 0.130 |
Why?
|
| Rhinitis | 1 | 2017 | 38 | 0.130 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2017 | 19 | 0.130 |
Why?
|
| Cleft Palate | 2 | 2009 | 154 | 0.130 |
Why?
|
| Foreign Bodies | 1 | 1998 | 109 | 0.130 |
Why?
|
| Cystic Fibrosis | 4 | 2002 | 266 | 0.130 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1998 | 223 | 0.130 |
Why?
|
| Texas | 1 | 2025 | 3716 | 0.130 |
Why?
|
| Pneumocystis | 1 | 1996 | 12 | 0.130 |
Why?
|
| Pediatricians | 1 | 2017 | 71 | 0.130 |
Why?
|
| Ear, External | 1 | 1996 | 23 | 0.130 |
Why?
|
| Maxillofacial Abnormalities | 1 | 2016 | 8 | 0.130 |
Why?
|
| Mouth Mucosa | 1 | 1996 | 54 | 0.130 |
Why?
|
| Pepsin A | 1 | 1996 | 12 | 0.130 |
Why?
|
| Papillomavirus Infections | 1 | 2021 | 396 | 0.120 |
Why?
|
| Gastric Acid | 1 | 1996 | 56 | 0.120 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 3 | 2002 | 47 | 0.120 |
Why?
|
| Acoustic Impedance Tests | 3 | 2010 | 7 | 0.120 |
Why?
|
| Candida albicans | 1 | 1996 | 89 | 0.120 |
Why?
|
| Age Factors | 3 | 2013 | 2997 | 0.120 |
Why?
|
| Burns, Chemical | 1 | 1996 | 31 | 0.120 |
Why?
|
| Surveys and Questionnaires | 6 | 2023 | 3999 | 0.120 |
Why?
|
| Immune System | 1 | 1996 | 98 | 0.120 |
Why?
|
| Acupuncture Therapy | 1 | 2015 | 13 | 0.120 |
Why?
|
| Hypoglossal Nerve Injuries | 1 | 1995 | 1 | 0.120 |
Why?
|
| Neck Injuries | 1 | 1995 | 24 | 0.110 |
Why?
|
| Genetic Therapy | 4 | 2002 | 737 | 0.110 |
Why?
|
| Intraoperative Care | 1 | 2015 | 120 | 0.110 |
Why?
|
| Androstadienes | 1 | 2014 | 52 | 0.110 |
Why?
|
| Patient Selection | 2 | 2020 | 735 | 0.110 |
Why?
|
| Chondroma | 1 | 2014 | 6 | 0.110 |
Why?
|
| Wounds, Penetrating | 1 | 1995 | 142 | 0.110 |
Why?
|
| Ribs | 1 | 2014 | 54 | 0.110 |
Why?
|
| Double-Blind Method | 4 | 2015 | 1665 | 0.110 |
Why?
|
| Respiratory Insufficiency | 1 | 2016 | 239 | 0.110 |
Why?
|
| Dilatation | 1 | 2013 | 71 | 0.110 |
Why?
|
| Adult | 12 | 2016 | 31930 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2017 | 2198 | 0.100 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2016 | 240 | 0.100 |
Why?
|
| Neuromuscular Agents | 1 | 2013 | 67 | 0.100 |
Why?
|
| Parents | 1 | 2020 | 1071 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 3 | 2023 | 2578 | 0.100 |
Why?
|
| Gastroesophageal Reflux | 1 | 1996 | 337 | 0.100 |
Why?
|
| Wound Healing | 1 | 1996 | 488 | 0.090 |
Why?
|
| Sampling Studies | 1 | 2011 | 79 | 0.090 |
Why?
|
| Maxillary Sinusitis | 3 | 2002 | 3 | 0.090 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2013 | 166 | 0.090 |
Why?
|
| Hypertrophy | 2 | 2003 | 105 | 0.090 |
Why?
|
| Risk Factors | 6 | 2011 | 11180 | 0.090 |
Why?
|
| Dependovirus | 3 | 2002 | 151 | 0.090 |
Why?
|
| Esophagoscopy | 1 | 2011 | 165 | 0.080 |
Why?
|
| Ear Diseases | 1 | 2010 | 21 | 0.080 |
Why?
|
| Bronchoscopy | 2 | 2009 | 173 | 0.080 |
Why?
|
| Propranolol | 1 | 2010 | 130 | 0.080 |
Why?
|
| Audiometry, Pure-Tone | 3 | 2010 | 25 | 0.080 |
Why?
|
| Otitis Media with Effusion | 1 | 2009 | 21 | 0.080 |
Why?
|
| Liver Transplantation | 1 | 1998 | 1128 | 0.080 |
Why?
|
| Prognosis | 3 | 2008 | 5086 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2011 | 3114 | 0.080 |
Why?
|
| Glottis | 1 | 2009 | 31 | 0.080 |
Why?
|
| Laryngostenosis | 1 | 2009 | 38 | 0.080 |
Why?
|
| Hearing Loss, Conductive | 1 | 2008 | 16 | 0.070 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2010 | 252 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 1340 | 0.070 |
Why?
|
| Immunophenotyping | 1 | 2009 | 342 | 0.070 |
Why?
|
| Microsurgery | 1 | 2008 | 65 | 0.070 |
Why?
|
| Syndrome | 3 | 2006 | 1161 | 0.070 |
Why?
|
| Consensus | 2 | 2022 | 732 | 0.070 |
Why?
|
| Students | 1 | 2010 | 260 | 0.070 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 1310 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1317 | 0.070 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2016 | 1000 | 0.060 |
Why?
|
| Microscopy | 1 | 2007 | 124 | 0.060 |
Why?
|
| Curriculum | 2 | 2024 | 764 | 0.060 |
Why?
|
| Vocal Cord Paralysis | 1 | 2007 | 69 | 0.060 |
Why?
|
| Ascites | 1 | 2007 | 111 | 0.060 |
Why?
|
| Laser Therapy | 1 | 2008 | 227 | 0.060 |
Why?
|
| Poverty | 1 | 2010 | 438 | 0.060 |
Why?
|
| Postoperative Complications | 4 | 2007 | 3178 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2017 | 1978 | 0.060 |
Why?
|
| Bradycardia | 1 | 2006 | 63 | 0.060 |
Why?
|
| Multigene Family | 1 | 2006 | 324 | 0.060 |
Why?
|
| Austria | 1 | 2024 | 20 | 0.060 |
Why?
|
| Infant Welfare | 1 | 2004 | 28 | 0.060 |
Why?
|
| Sex Factors | 1 | 2008 | 1387 | 0.060 |
Why?
|
| Oximetry | 1 | 2025 | 179 | 0.060 |
Why?
|
| Rabbits | 2 | 2014 | 729 | 0.050 |
Why?
|
| Child Welfare | 1 | 2004 | 67 | 0.050 |
Why?
|
| Adenoids | 1 | 2003 | 12 | 0.050 |
Why?
|
| Audiometry, Evoked Response | 1 | 2003 | 3 | 0.050 |
Why?
|
| Oral Surgical Procedures | 1 | 2003 | 14 | 0.050 |
Why?
|
| Nontuberculous Mycobacteria | 1 | 2023 | 25 | 0.050 |
Why?
|
| Speech Intelligibility | 1 | 2002 | 6 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 1071 | 0.050 |
Why?
|
| Speech Articulation Tests | 1 | 2002 | 8 | 0.050 |
Why?
|
| Aged | 2 | 2016 | 21772 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2004 | 282 | 0.050 |
Why?
|
| Otoscopes | 1 | 2002 | 5 | 0.050 |
Why?
|
| Tracheal Stenosis | 1 | 2022 | 33 | 0.050 |
Why?
|
| Young Adult | 1 | 2016 | 9935 | 0.050 |
Why?
|
| Patient Care | 1 | 2023 | 100 | 0.050 |
Why?
|
| Perioperative Care | 1 | 2004 | 211 | 0.050 |
Why?
|
| Administration, Oral | 2 | 2017 | 727 | 0.050 |
Why?
|
| Lymph Node Excision | 1 | 2023 | 176 | 0.050 |
Why?
|
| Hospital Volunteers | 1 | 2001 | 1 | 0.050 |
Why?
|
| Middle Aged | 3 | 2016 | 29394 | 0.050 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2001 | 25 | 0.050 |
Why?
|
| Audiometry | 1 | 2001 | 23 | 0.050 |
Why?
|
| Aging | 1 | 2009 | 1306 | 0.050 |
Why?
|
| Quality of Life | 2 | 2003 | 2160 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2022 | 239 | 0.050 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 3754 | 0.050 |
Why?
|
| Genetic Vectors | 3 | 2002 | 970 | 0.040 |
Why?
|
| Dilatation, Pathologic | 1 | 2001 | 93 | 0.040 |
Why?
|
| Peru | 2 | 2011 | 56 | 0.040 |
Why?
|
| Mastoiditis | 1 | 2001 | 33 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2001 | 165 | 0.040 |
Why?
|
| Trachea | 1 | 2022 | 212 | 0.040 |
Why?
|
| Program Development | 1 | 2001 | 190 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2006 | 977 | 0.040 |
Why?
|
| Internationality | 1 | 2021 | 138 | 0.040 |
Why?
|
| Ibuprofen | 1 | 2020 | 43 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2020 | 331 | 0.040 |
Why?
|
| Pregnancy | 2 | 2016 | 7570 | 0.040 |
Why?
|
| Canada | 1 | 2000 | 346 | 0.040 |
Why?
|
| Tracheotomy | 1 | 1999 | 36 | 0.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2001 | 243 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2001 | 457 | 0.040 |
Why?
|
| Airway Resistance | 1 | 1999 | 37 | 0.040 |
Why?
|
| HIV Infections | 1 | 2011 | 2075 | 0.040 |
Why?
|
| Income | 1 | 2019 | 140 | 0.040 |
Why?
|
| Parvoviridae Infections | 1 | 1999 | 37 | 0.040 |
Why?
|
| Acute Disease | 1 | 2002 | 1192 | 0.040 |
Why?
|
| Hospitalization | 2 | 1998 | 1906 | 0.040 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2007 | 1163 | 0.040 |
Why?
|
| Clinical Protocols | 2 | 1998 | 245 | 0.040 |
Why?
|
| Bronchography | 1 | 1998 | 6 | 0.040 |
Why?
|
| Data Collection | 1 | 2000 | 399 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2001 | 305 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2020 | 370 | 0.040 |
Why?
|
| Age of Onset | 1 | 2000 | 637 | 0.040 |
Why?
|
| Safety | 1 | 1999 | 217 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 333 | 0.040 |
Why?
|
| Patient Admission | 1 | 1999 | 190 | 0.040 |
Why?
|
| Drainage | 1 | 1999 | 265 | 0.040 |
Why?
|
| Nasal Sprays | 1 | 2017 | 8 | 0.030 |
Why?
|
| Time Factors | 3 | 2003 | 6610 | 0.030 |
Why?
|
| Quality Assurance, Health Care | 1 | 1999 | 221 | 0.030 |
Why?
|
| Incidence | 2 | 2009 | 3416 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 1998 | 152 | 0.030 |
Why?
|
| Genu Valgum | 1 | 2017 | 3 | 0.030 |
Why?
|
| Rickets | 1 | 2017 | 9 | 0.030 |
Why?
|
| Oral Ulcer | 1 | 2017 | 4 | 0.030 |
Why?
|
| Hypophosphatemia | 1 | 2017 | 10 | 0.030 |
Why?
|
| Triamcinolone | 1 | 2017 | 15 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2000 | 1200 | 0.030 |
Why?
|
| Alopecia | 1 | 2017 | 41 | 0.030 |
Why?
|
| Ear Cartilage | 1 | 1996 | 2 | 0.030 |
Why?
|
| Tubulin Modulators | 1 | 2016 | 11 | 0.030 |
Why?
|
| Phosphorus | 1 | 2017 | 61 | 0.030 |
Why?
|
| Calcitriol | 1 | 2017 | 81 | 0.030 |
Why?
|
| Vinblastine | 1 | 2016 | 58 | 0.030 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2017 | 48 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2019 | 279 | 0.030 |
Why?
|
| Nasal Septum | 1 | 1996 | 18 | 0.030 |
Why?
|
| Mercaptopurine | 1 | 2016 | 72 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 1999 | 291 | 0.030 |
Why?
|
| Caustics | 1 | 1996 | 5 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 2172 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2017 | 1249 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2017 | 163 | 0.030 |
Why?
|
| Prednisone | 1 | 2016 | 289 | 0.030 |
Why?
|
| Nose | 1 | 1996 | 105 | 0.030 |
Why?
|
| Anesthesia | 1 | 1998 | 213 | 0.030 |
Why?
|
| X Chromosome | 1 | 1996 | 342 | 0.030 |
Why?
|
| Hypoglossal Nerve | 1 | 1995 | 14 | 0.030 |
Why?
|
| Paralysis | 1 | 1995 | 29 | 0.030 |
Why?
|
| Patient Care Team | 1 | 1999 | 574 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 1190 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2021 | 700 | 0.030 |
Why?
|
| Fluticasone | 1 | 2014 | 15 | 0.030 |
Why?
|
| Homicide | 1 | 1995 | 35 | 0.030 |
Why?
|
| Surgery, Plastic | 1 | 1996 | 105 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2014 | 18 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 4807 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 1996 | 315 | 0.030 |
Why?
|
| Prevalence | 2 | 2011 | 2684 | 0.030 |
Why?
|
| Algorithms | 1 | 2021 | 1735 | 0.030 |
Why?
|
| Disease Management | 1 | 2017 | 566 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 1996 | 627 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2017 | 778 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 718 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 703 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 316 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 3043 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 2771 | 0.020 |
Why?
|
| Pilot Projects | 1 | 1996 | 1492 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 399 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2000 | 3742 | 0.020 |
Why?
|
| Otoscopy | 1 | 2010 | 8 | 0.020 |
Why?
|
| Otitis Media, Suppurative | 1 | 2010 | 5 | 0.020 |
Why?
|
| Exudates and Transudates | 1 | 2009 | 22 | 0.020 |
Why?
|
| Audiology | 1 | 2009 | 6 | 0.020 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2009 | 27 | 0.020 |
Why?
|
| Gene Transfer Techniques | 2 | 2002 | 365 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2009 | 114 | 0.020 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2008 | 11 | 0.020 |
Why?
|
| Connexin 26 | 1 | 2006 | 13 | 0.020 |
Why?
|
| Anion Transport Proteins | 1 | 2006 | 31 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2010 | 1338 | 0.020 |
Why?
|
| Connexins | 1 | 2006 | 65 | 0.020 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2007 | 147 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2006 | 251 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 842 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2006 | 563 | 0.010 |
Why?
|
| Animals | 2 | 2014 | 36545 | 0.010 |
Why?
|
| Instillation, Drug | 1 | 2002 | 7 | 0.010 |
Why?
|
| Nasal Lavage Fluid | 1 | 2002 | 14 | 0.010 |
Why?
|
| Administration, Intranasal | 1 | 2002 | 138 | 0.010 |
Why?
|
| Genes, Viral | 1 | 2002 | 186 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2002 | 191 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2002 | 225 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2009 | 1721 | 0.010 |
Why?
|
| Sickness Impact Profile | 1 | 2000 | 39 | 0.010 |
Why?
|
| Point Mutation | 1 | 1999 | 362 | 0.010 |
Why?
|
| Maxillofacial Development | 1 | 1996 | 2 | 0.010 |
Why?
|
| Nasal Obstruction | 1 | 1996 | 15 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 1331 | 0.010 |
Why?
|
| Anthropometry | 1 | 1996 | 205 | 0.010 |
Why?
|
| Recurrence | 1 | 1999 | 1472 | 0.010 |
Why?
|
| Models, Biological | 1 | 1999 | 1539 | 0.010 |
Why?
|